Formyl Peptide Receptor 1 and 2 Dual Agonist Inhibits Human Neutrophil Chemotaxis by the Induction of Chemoattractant Receptor Cross-desensitization

スポンサーリンク

概要

• 論文の詳細を見る
• 2011-01-20

著者

• Hirahara Kazuki

  Biological Research Laboratories Iii Daiichi Sankyo Co. Ltd.

• Sogawa Yoshitaka

  Cardiovascular-metabolics Research Laboratories Daiichi Sankyo Co. Ltd.

• Ohyama Takao

  Biologics Research Laboratories Daiichi Sankyo Co. Ltd.

• Hirahara Kazuki

  Frontier Research Laboratories Daiichi Sankyo Co. Ltd.

• Maeda Hiroaki

  Frontier Research Laboratories Daiichi Sankyo Co. Ltd.

関連論文

• Formyl Peptide Receptor 1 and 2 Dual Agonist Inhibits Human Neutrophil Chemotaxis by the Induction of Chemoattractant Receptor Cross-desensitization
• The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX-Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist
• Formyl Peptide Receptor 1 and 2 Dual Agonist Inhibits Human Neutrophil Chemotaxis by the Induction of Chemoattractant Receptor Cross-desensitization
• Evaluation of the Therapeutic Index of a Novel Phosphodiesterase 4B–Selective Inhibitor Over Phosphodiesterase 4D in Mice

スポンサーリンク